Pateclizumab Biosimilar – Anti-LTA, TNFSF1 mAb – Research Grade

Reference:
Product namePateclizumab Biosimilar - Anti-LTA, TNFSF1 mAb - Research Grade
SourceCAS 1202526-59-7
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsPateclizumab,MLTA3698A,PRO283698,RG7416,LTA, TNFSF1,anti-LTA, TNFSF1
ReferencePX-TA1273
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Pateclizumab Biosimilar - Anti-LTA/TNFSF1 mAb - Research Grade

General information on Anti-LTA/TNFSF1[Homo sapiens] (Pateclizumab) Monoclonal Antibody

Pateclizumab is investigated for the treatment of Active Rheumatoid Arthritis.

SDS-PAGE for Pateclizumab Biosimilar - Anti-LTA, TNFSF1 mAb

Pateclizumab Biosimilar - Anti-LTA, TNFSF1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Pateclizumab Biosimilar – Anti-LTA, TNFSF1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Galectin-9(LGALS9)
Antigen

Galectin-9(LGALS9)

PX-P4585 210€
Receptor-interacting serine, threonine-protein kinase 4(RIPK4)
Antigen

Receptor-interacting serine, threonine-protein kinase 4(RIPK4)

PX-P4863 210€
T cell receptor delta variable 1(TRDV1)
Antigen

T cell receptor delta variable 1(TRDV1)

PX-P4655 210€
Glycophorin-B(GYPB)
Antigen

Glycophorin-B(GYPB)

PX-P4686 210€
LTA recombinant protein
Antigen

LTA recombinant protein

PX-P5015 385€
Human DLL4 recombinant protein
Antigen

Human DLL4 recombinant protein

PX-P5121 110€
SARS-CoV-2 RBD of Spike protein, L452R, T478K – lineage B.1.617.2 – Indian Delta Variant
Antigen

SARS-CoV-2 RBD of Spike protein, L452R, T478K – lineage B.1.617.2 – Indian Delta Variant

PX-COV-P061 250€
SARS-CoV-2 RBD of Spike protein, K417N, T478K, L452R– lineage B.1.617.2.1 – Indian Delta Plus Variant
Antigen

SARS-CoV-2 RBD of Spike protein, K417N, T478K, L452R– lineage B.1.617.2.1 – Indian Delta Plus Variant

PX-COV-P062 250€
Stable Isotope Labelled Pateclizumab Biosimilar – Anti-LTA/TNFSF1 mAb – Research Grade
SIL

Stable Isotope Labelled Pateclizumab Biosimilar – Anti-LTA/TNFSF1 mAb – Research Grade

PX-TA1273-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products